EcoDrugPlus

Opioid Receptor Delta 1

Ensembl ID : ENSAMXG00000032485
Gene Symbol: OPRD1
1 Cross references
187 Possible Orthologues:

Opioid Receptor, Delta 1b

Ensembl ID : ENSAMXG00000029726
Gene Symbol: OPRD1B
1 Cross references
138 Possible Orthologues:

Opioid Related Nociceptin Receptor 1

Ensembl ID : ENSAMXG00000036124
Gene Symbol: OPRL1
3 Cross references
191 Possible Orthologues:

Opioid Related Nociceptin Receptor 1

Ensembl ID : ENSAMXG00000038862
Gene Symbol: OPRL1
2 Cross references
132 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSAMXG00000039096
Gene Symbol: OXTR
3 Cross references
186 Possible Orthologues:

P21 (Rac1) Activated Kinase 4

Ensembl ID : ENSAMXG00000008603
Gene Symbol: PAK4
3 Cross references
163 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSAMXG00000019410
Gene Symbol: PTH1R
1 Cross references
198 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSAMXG00000008963
Gene Symbol: PPARD
3 Cross references
352 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSAMXG00000041846
Gene Symbol: PPARD
3 Cross references
392 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSAMXG00000043041
Gene Symbol: PPARG
4 Cross references
390 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha

Ensembl ID : ENSAMXG00000034838
Gene Symbol: LOC103027723
3 Cross references
384 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha B

Ensembl ID : ENSAMXG00000043711
Gene Symbol: PPARAB
1 Cross references
397 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).